Microarray expression profiling identifies early signaling transcripts associated with 6-OHDA-induced dopaminergic cell death

Antioxidants and Redox Signaling

Volumn 7, Issue 5-6, 2005, Pages 639-648

  Holtz, William A ^a   Turetzky, Jay M ^a   O'Malley, Karen L ^a  

^a WASHINGTON UNIVERSITY SCHOOL OF MEDICINE   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

ACTIVATING TRANSCRIPTION FACTOR 3; ACTIVATING TRANSCRIPTION FACTOR 4; AMINO ACID TRANSFER RNA LIGASE; CCAAT ENHANCER BINDING PROTEIN BETA; GENE PRODUCT; GROWTH ARREST AND DNA DAMAGE INDUCIBLE PROTEIN 153; HEME OXYGENASE 1; OXIDOPAMINE; PROTEIN HERPUD1; PROTEIN POR; PROTEIN SQSTM1; RNA; TRANSCRIPTION FACTOR; UBIQUITIN; UNCLASSIFIED DRUG;

ARTICLE; CONTROLLED STUDY; DNA MICROARRAY; DOPAMINERGIC NERVE CELL; FUNCTIONAL GENOMICS; FUNCTIONAL PROTEOMICS; GENE EXPRESSION; HUMAN; HUMAN CELL; NERVE CELL NECROSIS; NEUROTOXICITY; OXIDATIVE STRESS; PARKINSON DISEASE; PRIORITY JOURNAL; PROTEIN DEGRADATION; PROTEIN MODIFICATION; PROTEIN SYNTHESIS; REAL TIME POLYMERASE CHAIN REACTION; STRESS; TRANSCRIPTION REGULATION; TWO DIMENSIONAL GEL ELECTROPHORESIS; WESTERN BLOTTING;

ANIMALS; CELL DEATH; CELL LINE; CLUSTER ANALYSIS; ELECTROPHORESIS, GEL, TWO-DIMENSIONAL; GENE EXPRESSION PROFILING; HEME OXYGENASE (DECYCLIZING); HEME OXYGENASE-1; KINETICS; MEMBRANE PROTEINS; MICE; OLIGONUCLEOTIDE ARRAY SEQUENCE ANALYSIS; OXIDATIVE STRESS; OXIDOPAMINE; REVERSE TRANSCRIPTASE POLYMERASE CHAIN REACTION; RNA, MESSENGER; SIGNAL TRANSDUCTION; TIME FACTORS; TRANSCRIPTION, GENETIC;

EID: 17644407706     PISSN: 15230864     EISSN: None     Source Type: Journal    
DOI: 10.1089/ars.2005.7.639     Document Type: Article

References (33)

1. Blum D, Torch S, Lambeng N, Nissou M, Benabid AL, Sadoul R, and Verna JM. Molecular pathways involved in the neurotoxicity of 6-OHDA, dopamine and MPTP: contribution to the apoptotic theory in Parkinson's disease. Prog Neurobiol 65: 135-172, 2001.
2. Choi HK, Won LA, Kontur PJ, Hammond DN, Fox AP, Wainer BH, Hoffmann PC, and Heller A. Immortalization of embryonic mesencephalic dopaminergic neurons by somatic cell fusion. Brain Res 552: 67-76, 1991.
3. +-induced cell death in a dopaminergic neuronal cell line: role of macromolecule synthesis, cytosolic calcium, caspase, and Bcl-2-related proteins. Exp Neurol 159: 274-282, 1999.
4. +-induced dopaminergic neuronal cell death: role of caspases, ROS, and JNK. J Neurosci Res 57: 86-94, 1999.
5. +, oxidant and specific neurotoxicants shares the common molecular mechanism. J Neurochem 76: 1010-1021, 2001.
6. Curtius HC, Wolfensberger M, Steinmann B, Redweik U, and Siegfried J. Mass fragmentography of dopamine and 6-hydroxydopamine. Application to the determination of dopamine in human brain biopsies from the caudate nucleus. J Chromatogr 99: 529-540, 1974.
7. Dawson T, Mandir A, and Lee M. Animal models of PD: pieces of the same puzzle? Neuron 35: 219-222, 2002.
8. Dawson TM and Dawson VL. Molecular pathways of neurodegeneration in Parkinson's disease. Science 302: 819-822, 2003.
9. Diamond RH, Du K, Lee VM, Mohn KL, Haber BA, Tewari DS, and Taub R. Novel delayed-early and highly insulin-induced growth response genes. Identification of HRS, a potential regulator of alternative pre-mRNA splicing. J Biol Chem 268: 15185-15192, 1993.
10. Du K, Leu JI, Peng Y, and Taub R. Transcriptional up-regulation of the delayed early gene HRS/SRp40 during liver regeneration. Interactions among YY1, GA-binding proteins, and mitogenic signals. J Biol Chem 273: 35208-35215, 1998.
11. Fornstedt B, Rosengren E, and Carlsson A. Occurrence and distribution of 5-S-cysteinyl derivatives of dopamine, dopa and dopac in the brains of eight mammalian species. Neuropharmacology 25: 451-454, 1986.
12. Han BS, Hong HS, Choi WS, Markelonis GJ, Oh TH, and Oh YJ. Caspase-dependent and -independent cell death pathways in primary cultures of mesencephalic dopaminergic neurons after neurotoxin treatment. J Neurosci 23: 5069-5078, 2003.
13. Harding HP, Zhang Y, Zeng H, Novoa I, Lu PD, Calfon M, Sadri N, Yun C, Popko B, Paules R, Stojdl DF, Bell JC, Hettmann T, Leiden JM, and Ron D. An integrated stress response regulates amino acid metabolism and resistance to oxidative stress. Mol Cell 11: 619-633, 2003.
14. Hashimoto Y, Zhang C, Kawauchi J, Imoto I, Adachi MT, Inazawa J, Amagasa T, Hai T, and Kitajima S. An alternatively spliced isoform of transcriptional represser ATF3 and its induction by stress stimuli. Nucleic Acids Res 30: 2398-2406, 2002.
15. Holtz WA and O'Malley KL. Parkinsonian mimetics induce aspects of unfolded protein response in death of dopaminergic neurons. J Biol Chem 278: 19367-19377, 2003.
16. Jiang HY, Wek SA, McGrath BC, Lu D, Hai T, Harding HP, Wang X, Ron D, Cavener DR, and Wek RC. Activating transcription factor 3 is integral to the eukaryotic initiation factor 2 kinase stress response. Mol Cell Biol 24: 1365-1377, 2004.
17. Kuusisto E, Suuronen T, and Salminen A. Ubiquitin-binding protein p62 expression is induced during apoptosis and proteasomal inhibition in neuronal cells. Biochem Biophys Res Commun 280: 223-228, 2001.
18. Kuusisto E, Parkkinen L, and Alafuzoff I. Morphogenesis of Lewy bodies: dissimilar incorporation of alpha-synuclein, ubiquitin, and p62. J Neuropathol Exp Neurol 62: 1241-1253, 2003.
19. Lansbury PT Jr and Brice A. Genetics of Parkinson's disease and biochemical studies of implicated gene products. Curr Opin Cell Biol 14: 653-660, 2002.
20. Lee K, Tirasophon W, Shen X, Michalak M, Prywes R, Okada T, Yoshida H, Mori K, and Kaufman RJ. IRE1-mediated unconventional mRNA splicing and S2P-mediated ATF6 cleavage merge to regulate XBP1 in signaling the unfolded protein response. Genes Dev 16: 452-466, 2002.
21. Morrison TB, Weis JJ, and Wittwer CT. Quantification of low-copy transcripts by continuous SYBR Green I monitoring during amplification. Biotechniques 24: 954-958, 960, 962, 1998.
22. Nagarajan R, Le N, Mahoney H, Araki T, and Milbrandt J. Deciphering peripheral nerve myelination by using Schwann cell expression profiling. Proc Natl Acad Sci USA 99: 8998-9003, 2002.
23. Pan Y, Chen H, Siu F, and Kilberg MS. Amino acid deprivation and endoplasmic reticulum stress induce expression of multiple activating transcription factor-3 mRNA species that, when overexpressed in HepG2 cells, modulate transcription by the human asparagine synthetase promoter. J Biol Chem 278: 38402-38412, 2003.
24. Ryu EJ, Harding HP, Angelastro JM, Vitolo OV, Ron D, and Greene LA. Endoplasmic reticulum stress and the unfolded protein response in cellular models of Parkinson's disease. J Neurosci 22: 10690-10698, 2002.
25. Salinas M, Diaz R, Abraham NG, Ruiz de Galarreta CM, and Cuadrado A. Nerve growth factor protects against 6-hydroxydopamine-induced oxidative stress by increasing expression of heme oxygenase-1 in a phosphatidylinositol 3-kinase-dependent manner. J Biol Chem 278: 13898-13904, 2003.
26. Schagger H and von Jagow G. Blue native electrophoresis for isolation of membrane protein complexes in enzymatically active form. Anal Biochem 199: 223-231, 1991.
27. Schipper HM, Liberman A, and Stopa EG. Neural heme oxygenase-1 expression in idiopathic Parkinson's disease. Exp Neurol 150: 60-68, 1998.
28. Siderowf A and Stern M. Update on Parkinson disease. Ann Intern Med 138: 651-658, 2003.
29. Spencer JP, Jenner P, Daniel SE, Lees AJ, Marsden DC, and Halliwell B. Conjugates of catecholamines with cysteine and GSH in Parkinson's disease: possible mechanisms of formation involving reactive oxygen species. J Neurochem 71: 2112-2122, 1998.
30. Stokes AH, Hastings TG, and Vrana KE. Cytotoxic and genotoxic potential of dopamine. J Neurosci Res 55: 659-665, 1999.
31. Yoo MS, Chun HS, Son JJ, DeGiorgio LA, Kim DJ, Peng C, and Son JH. Oxidative stress regulated genes in nigral dopaminergic neuronal cells: correlation with the known pathology in Parkinson's disease. Brain Res Mol Brain Res 110: 76-84, 2003.
32. Yoshida H, Matsui T, Yamamoto A, Okada T, and Mori K. XBP1 mRNA is induced by ATF6 and spliced by IRE1 in response to ER stress to produce a highly active transcription factor. Cell 107: 881-891, 2001.
33. Zatloukal K, Stumptner C, Fuchsbichler A, Heid H, Schnoelzer M, Kenner L, Kleinert R, Prinz M, Aguzzi A, and Denk H. p62 is a common component of cytoplasmic inclusions in protein aggregation diseases. Am J Pathol 160: 255-263,2002.